Title : Deferoxamine inhibits TRAIL-mediated apoptosis via regulation of autophagy in human colon cancer cells.

Pub. Date : 2015 Mar

PMID : 25524470






9 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Deferoxamine inhibits TRAIL-mediated apoptosis via regulation of autophagy in human colon cancer cells. Deferoxamine TNF superfamily member 10 Homo sapiens
2 The present study investigated the effects of DFO on TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in colon cancer cells and and the mechanism involved. Deferoxamine TNF superfamily member 10 Homo sapiens
3 The present study investigated the effects of DFO on TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in colon cancer cells and and the mechanism involved. Deferoxamine TNF superfamily member 10 Homo sapiens
4 The experimental results showed that DFO treatment inhibited TRAIL-mediated cancer cell apoptosis by increasing Akt activation and decreasing caspase activation in human colon cancer cells. Deferoxamine TNF superfamily member 10 Homo sapiens
5 Furthermore, DFO treatment induced autophagy flux, and chloroquine, an autophagy inhibitor, blocked DFO-mediated inhibition of TRAIL-induced apoptosis. Deferoxamine TNF superfamily member 10 Homo sapiens
6 The present study demonstrated that DFO inhibited TRAIL-mediated tumor cell death via the autophagy pathway, and the results suggest that potent anticancer agent, DFO, can be an inhibitor against antitumor therapy including TRAIL protein. Deferoxamine TNF superfamily member 10 Homo sapiens
7 The present study demonstrated that DFO inhibited TRAIL-mediated tumor cell death via the autophagy pathway, and the results suggest that potent anticancer agent, DFO, can be an inhibitor against antitumor therapy including TRAIL protein. Deferoxamine TNF superfamily member 10 Homo sapiens
8 The present study demonstrated that DFO inhibited TRAIL-mediated tumor cell death via the autophagy pathway, and the results suggest that potent anticancer agent, DFO, can be an inhibitor against antitumor therapy including TRAIL protein. Deferoxamine TNF superfamily member 10 Homo sapiens
9 The present study demonstrated that DFO inhibited TRAIL-mediated tumor cell death via the autophagy pathway, and the results suggest that potent anticancer agent, DFO, can be an inhibitor against antitumor therapy including TRAIL protein. Deferoxamine TNF superfamily member 10 Homo sapiens